SENATE RULES COMMITTEE SR 87
Office of Senate Floor Analyses
(916) 651-1520 Fax: (916) 327-4478
THIRD READING
Bill No: SR 87
Author: Blakespear (D)
Introduced: 4/10/24
Vote: Majority
SUBJECT: Tardive Dyskinesia Awareness Week
SOURCE: Neurocrine Biosciences
DIGEST: This resolution proclaims the week of May 6, 2024, as Tardive
Dyskinesia Awareness Week in California, and commends the observance of the
week to all residents of the state.
ANALYSIS: This resolution makes the following legislative findings:
1) Many people with serious mental health conditions, such as bipolar disorder,
major depression, schizophrenia, and schizoaffective disorder, or
gastrointestinal disorders, including gastroparesis, nausea, and vomiting, may
be treated with medications that work as dopamine receptor blocking agents
(DRBAs), including antipsychotics and antiemetics.
2) While ongoing treatment with these medications can be necessary, prolonged
use can also lead to Tardive Dyskinesia (TD), an involuntary movement
disorder that is characterized by uncontrollable, abnormal, and repetitive
movements of the face, torso, limbs, fingers, or toes that can impact people
physically, socially, and emotionally.
3) It is estimated that TD affects approximately 600,000 people in the United
States and approximately 65 percent of people with TD remain undiagnosed,
making it important to raise awareness about the symptoms.
4) It is important for people taking these medications be monitored for TD by a
health care provider. Regular screening for TD in these patients is
recommended by the American Psychiatric Association.
SR 87
Page 2
This resolution proclaims the week of May 6, 2024, as Tardive Dyskinesia
Awareness Week in California, and commends the observance of the week to all
residents of the state.
Related/Prior Legislation
The following are the most recent measures relating to Tardive Dyskinesia
Awareness Week:
SR 30 (Blakespear, 2023) – adopted by the Senate on May 8, 2023.
SR 67 (Archuleta, 2022) – adopted by the Senate on May 9, 2022.
SR 20 (Archuleta, 2021) – adopted by the Senate on May 3, 2021.
SR 73 (Archuleta, 2020) – adopted by the Senate on June 11, 2020.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 4/15/24)
Neurocrine Biosciences (source)
OPPOSITION: (Verified 4/15/24)
None received
Prepared by: Russell Manning / SFA / (916) 651-1520
4/17/24 15:49:55
**** END ****